Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2026 08:00 ET | Source: Freenome, Inc.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
July 22, 2026 05:30 ET | Source: Research and Markets

Liquid Biopsy Market Report 2026 | Projected to Reach $33.45 Billion by 2035, Driven by Advances in Cancer Diagnostics | Technologies, Samples, Biomarkers, 18 Cancer Types, Applications, and End Users

Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market (5th Edition) by Type of Technology, Type of Sample, Type of Circulating Biomarker, Type of Cancer, Application, End-user and...
July 20, 2026 16:01 ET | Source: Freenome, Inc.

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
June 25, 2026 04:30 ET | Source: SNS Insider pvt ltd

Breast Cancer Liquid Biopsy Market Size to Reach USD 3.42 Billion by 2035 | SNS Insider

Austin, United States, June 25, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Breast Cancer Liquid Biopsy Market Size was valued at USD 1.33 Billion in 2025 and is projected to reach USD...
June 22, 2026 11:30 ET | Source: SNS Insider pvt ltd

Laboratory Developed Tests Market Size to Reach USD 28.31 Billion by 2035 | SNS Insider

Austin, United States, June 22, 2026 (GLOBE NEWSWIRE) -- The Laboratory Developed Tests Market was valued at USD 14.27 Billion in 2025 and is expected to reach USD 28.31 Billion by 2035, growing at...
May 31, 2026 10:00 ET | Source: Precede Biosciences, Inc.

Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC

Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLCPlasma MET test showed high concordance with tissue...
May 15, 2026 09:49 ET | Source: BCC Research LLC

AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment

How chronic disease prevalence, infectious disease testing, AI investment, personalized medicine and regulatory change are shaping the diagnostics industry
April 21, 2026 14:30 ET | Source: Precede Biosciences, Inc.

Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026

Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gene expression, pathway activity, and cell states from just 1 mL of plasmaAACR studies demonstrate the...
March 20, 2026 06:49 ET | Source: Research and Markets

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The...
March 13, 2026 08:47 ET | Source: Research and Markets

Exosome Research Market Analysis, Opportunity Forecasts Report 2026-2035

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Exosome Research Market Analysis, Opportunity Forecasted For 2026-2035" has been added to ResearchAndMarkets.com's offering. The exosome...